Trial · NCT01294553
Adverse events15
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 15 of 15
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory tract infection | Immune system disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 17 | 713 | |
| other | Oedema | Metabolism and nutrition disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 16 | 713 | |
| other | Gastritis | Gastrointestinal disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 9 | 713 | |
| other | Weight increase | General disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 8 | 713 | |
| other | Dyspepsia | Gastrointestinal disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 6 | 713 | |
| other | Headache | General disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 6 | 713 | |
| other | Dysaesthesia | Nervous system disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 5 | 713 | |
| other | Chest pain | General disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 4 | 713 | |
| other | Constipation | Gastrointestinal disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 3 | 713 | |
| other | Fatigue | General disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 3 | 713 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 3 | 713 | |
| other | Impotence | Reproductive system and breast disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 3 | 713 | |
| serious | Hyperglycaemia | Metabolism and nutrition disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 1 | 713 | |
| serious | Chest pain | General disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 1 | 713 | |
| serious | Pneumonia | Immune system disorders | Avandamet 1/500, 2/500, 4/500, 2/1000, or 4/1000 mg | 1 | 713 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01294553/events